MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

    M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate the frequency of non motor fluctuations (NMF) in Parkinson's disease (PD), their correlation with motor complications and their impact on the quality…
  • 2019 International Congress

    A Dual-Center Study of Pain and Other Non-motor Symptoms in Parkinson disease

    P. Ghosh, P. Imbriani, N. Caputi, L. Covington, A. Sparks, T. Schirinzi, Y. Salnikova, S. Natoli, A. Pisani (Washington Dc, DC, USA)

    Objective: This study aims to explore the relationship between pain and other non-motor symptoms in Parkinson Disease (PD). Background: Pain is a common non-motor symptom…
  • 2019 International Congress

    Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial

    C. Mcdonald, J. Rees, K. Winge, J. Newton, D. Burn (Gateshead, United Kingdom)

    Objective: To assess the feasibility and efficacy of bladder training for troublesome lower urinary tract symptoms in Parkinson’s disease. Background: Lower urinary tract symptoms (LUTS)…
  • 2019 International Congress

    No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease

    E. Honkanen, L. Saari, K. Orte, M. Gardberg, T. Noponen, J. Joutsa, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to investigate if dopamine transporter (DAT) binding is associated with dopaminergic neurites in the putamen. Background: Dopamine transporter…
  • 2019 International Congress

    Metabolic network abnormalities in drug-naive Parkinson’s disease

    O. Lucas-Jimenez, K. Schindlbeck, C. Tang, S. Morbelli, D. Arnaldi, M. Pardini, M. Pagani, F. Nobili, D. Eidelberg (Bilbao, Spain)

    Objective: The objective of this study is to identify and validate the metabolic PD-related pattern (PDRP) in de novo PD patients and to compare it…
  • 2019 International Congress

    Micro structural Changes in Substantia Nigra are associated with Severity of Parkinson’s Disease.

    A. Safai, S. Rane, S. Prasad, J. Saini, P. Pal, M. Ingalhalikar (Pune, India)

    Objective: The aim of this study was to apply diffusion tensor imaging (DTI) to evaluate atrophy of the Substantia Nigra pars compacta (SNc), the pathological…
  • 2019 International Congress

    Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia

    G. Fabiani, FMB. Germiniani, HA. Teive (Curitiba, Brazil)

    Objective: Our main objective is to demonstrate the challenges involved in the diagnosis of parkinsonism in a patient with transverse failure of formation of the…
  • 2019 International Congress

    Stability and reliability of objective measures of speech in Parkinson’s Disease over 12 months

    M. Magee, J. Tamplin, C. Marigliani, F. Baker, M. Morris, A. Vogel (Melbourne, Australia)

    Objective: To describe the stability and reliability of acoustic measures of speech in Parkinson’s Disease (PD) at 3 and 12 months. Background: Speech biomarkers hold…
  • 2019 International Congress

    Effects of Cognitively Challenging Agility Exercise Program on Clinical and Objective Measures in People with Parkinson’s Disease

    P. Carlson-Kuhta, N. Hasegawa, SH. Jung, V. Shah, A. Ragothaman, D. Peterson, K. Smulders, L. King, M. Mancini, J. Lapidus, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To investigate the effects of a 6-week cognitively challenging exercise intervention in people with Parkinson’s disease (PD). Background: Gait and balance impairments have been…
  • 2019 International Congress

    Formulations and evaluations of Intranasal Nose to Brain Delivery of Curcumin with resveratrol Nanoparticle for treatment of Parkisonism

    A. Jain, S. Jain (Sagar, India)

    Objective: Parkinson’s disease (PD) is a common neurodegenerative disease characterized by motor symptoms of tremor, rigidity, bradykinesia, and postural instability. Growing evidence indicates that resveratrol…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley